27th May 2025 10:25
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.
----------
AIM - WINNERS
----------
Jangada Mines PLC, up 29% at 1.29 pence, 12-month range 0.59p-1.50p. The London-based and Brazil-focused miner notes investee Blencowe Resources PLC's receipt of the latest USD500,000 disbursement from the US International Development Finance Corp. This takes the total funds received by Blencowe under the USD5.0 million technical assistance grant to USD4.0 million. Jangada Chair Brian McMaster says: "The achievements over the quarter mark great progress and importantly the positive micronisation results translate into a significant uplift to the basket price, increasing the value of the product and underpinning Blencowe's end-to-end processing strategy. We look forward to further news in the near term, on-ground advancements and the completion of the [definitive feasibility study], which we believe will trigger a significant revaluation of Blencowe's share price." Jangada owns an around 7% stake in Blencowe.
----------
Poolbeg Pharma PLC, up 18% at 2.90p, 12-month range 2.25p-14.50p. The London-based clinical stage biopharmaceutical company targeting diseases reports the US Food & Drug Administration has granted orphan drug designation to its POLB 001 therapy as an oral preventative treatment for T-cell engager bispecific antibody-induced cytokine release syndrome. There are currently no approved preventative therapies for CRS. Poolbeg expects the first patient to be dosed in its proposed phase 2a study in the second half of 2025, with interim analysis expected in the first half of 2026 and topline data in the second half of 2026. Chief Executive Officer Jeremy Skillington believes the designation will "enhance the commercial appeal for prospective partners and help bring POLB 001 to the market faster". He continues: "If approved, we believe POLB 001 has the potential to improve quality of life for patients, reduce pressure on healthcare systems, and expand access to cancer immunotherapies."
----------
AIM - LOSERS
----------
React Group PLC, down 24% at 55.00p, 12-month range 55.00p-98.00p. The Birmingham, England-based provider of cleaning and soft facilities management services swings to an operating loss of GBP116,000 in the six months that ended March 31, from a GBP308,000 profit the year before. This is despite revenue growing 14% to GBP12.1 million from GBP10.6 million, as administrative expenses increase 34% to GBP3.9 million from GBP2.9 million and cost of sales rise 6.5% to GBP8.2 million from GBP7.7 million. "The board is taking a more cautious approach with respect to the expected outturn for the current financial year but firmly believes that React is well positioned to capitalise on an improvement in the economy," says Chief Executive Officer Shaun Doak. The firm now anticipates full-year results below market expectations.
----------
By Emily Parsons, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
Jangada MinesPoolbeg PharmaReact Group